Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
European Heart Journal. Digital Health
|
March 20, 2024
International evaluation of an artificial intelligence-powered electrocardiogram model detecting acute coronary occlusion myocardial infarction
Robert Herman, Harvey Pendell Meyers, Stephen W Smith, et al.
American Heart Journal
|
March 21, 2016
Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial
Marko Banovic, Bernard Iung, Jozef Bartunek, et al.
Open Heart
|
October 18, 2024
Clinical development and proof of principle testing of new regenerative vascular endothelial growth factor-D therapy for refractory angina: rationale and design of the phase 2 ReGenHeart trial
Aleksi J Leikas, Juha E K Hartikainen, Jens Kastrup, et al.
European Heart Journal
|
September 1, 2024
Aortic valve replacement vs. conservative treatment in asymptomatic severe aortic stenosis: long-term follow-up of the AVATAR trial
Marko Banovic, Svetozar Putnik, Bruno R Da Costa, et al.
European Journal of Heart Failure
|
January 16, 2023
Effect of allogeneic adipose tissue-derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction - the SCIENCE trial
Abbas Ali Qayyum, Bas van Klarenbosch, Sabina Frljak, et al.
European Journal of Heart Failure
|
September 27, 2017
The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial
Anthony Mathur, Roman Arnold, Birgit Assmus, et al.
Lancet (London, England)
|
December 7, 2024
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): an international, multicentre, prospective, open-label, non-inferiority, randomised controlled trial
Elvin Kedhi, Renicus S Hermanides, Jan-Henk E Dambrink, et al.
Open Heart
|
August 26, 2025
Adverse cardiovascular events in coronary Plaques not undeRgoing pErcutaneous coronary intervention evaluateD with optIcal Coherence Tomography. The PREDICT-AI risk model
Francesco Bruno, Maddalena Immobile Molaro, Michela Sperti, et al.
American Heart Journal
|
February 3, 2024
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationale
Elvin Kedhi, Andi Rroku, Rik S Hermanides, et al.
Journal of the American Heart Association
|
March 27, 2024
Risk Score for Prediction of Dialysis After Transcatheter Aortic Valve Replacement
Vincenzo Pasceri, Francesco Pelliccia, Roxana Mehran, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
European Heart Journal. Digital Health
|
March 20, 2024
International evaluation of an artificial intelligence-powered electrocardiogram model detecting acute coronary occlusion myocardial infarction
Robert Herman, Harvey Pendell Meyers, Stephen W Smith, et al.
American Heart Journal
|
March 21, 2016
Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial
Marko Banovic, Bernard Iung, Jozef Bartunek, et al.
Open Heart
|
October 18, 2024
Clinical development and proof of principle testing of new regenerative vascular endothelial growth factor-D therapy for refractory angina: rationale and design of the phase 2 ReGenHeart trial
Aleksi J Leikas, Juha E K Hartikainen, Jens Kastrup, et al.
European Heart Journal
|
September 1, 2024
Aortic valve replacement vs. conservative treatment in asymptomatic severe aortic stenosis: long-term follow-up of the AVATAR trial
Marko Banovic, Svetozar Putnik, Bruno R Da Costa, et al.
European Journal of Heart Failure
|
January 16, 2023
Effect of allogeneic adipose tissue-derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction - the SCIENCE trial
Abbas Ali Qayyum, Bas van Klarenbosch, Sabina Frljak, et al.
European Journal of Heart Failure
|
September 27, 2017
The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial
Anthony Mathur, Roman Arnold, Birgit Assmus, et al.
Lancet (London, England)
|
December 7, 2024
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): an international, multicentre, prospective, open-label, non-inferiority, randomised controlled trial
Elvin Kedhi, Renicus S Hermanides, Jan-Henk E Dambrink, et al.
Open Heart
|
August 26, 2025
Adverse cardiovascular events in coronary Plaques not undeRgoing pErcutaneous coronary intervention evaluateD with optIcal Coherence Tomography. The PREDICT-AI risk model
Francesco Bruno, Maddalena Immobile Molaro, Michela Sperti, et al.
American Heart Journal
|
February 3, 2024
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationale
Elvin Kedhi, Andi Rroku, Rik S Hermanides, et al.
Journal of the American Heart Association
|
March 27, 2024
Risk Score for Prediction of Dialysis After Transcatheter Aortic Valve Replacement
Vincenzo Pasceri, Francesco Pelliccia, Roxana Mehran, et al.
Page
of 6